{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T06:44:49Z","timestamp":1792219489889,"version":"4.4.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T00:00:00Z","timestamp":1776470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":60,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Orthop Surg Res"],"DOI":"10.1186\/s13018-026-06857-6","type":"journal-article","created":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T13:05:33Z","timestamp":1776517533000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Low-dose erythropoietin in anemic arthroplasty patients within contemporary patient blood management pathways"],"prefix":"10.1186","volume":"21","author":[{"given":"Herv\u00e9","family":"Hourlier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Fricault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Fennema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,18]]},"reference":[{"key":"6857_CR1","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1186\/s13018-024-04706-y","volume":"19","author":"FQ Zhang","year":"2024","unstructured":"Zhang FQ, Yang YZ, Li PF, Ma GR, Zhang AR, Zhang H, Guo HZ. Impact of preoperative anemia on patients undergoing total joint replacement of lower extremity: a systematic review and meta-analysis. J Orthop Surg Res. 2024;19:249.","journal-title":"J Orthop Surg Res"},{"key":"6857_CR2","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1186\/s13018-019-1329-0","volume":"14","author":"K Song","year":"2019","unstructured":"Song K, Pan P, Yao Y, Jiang T, Jiang Q. The incidence and risk factors for allogenic blood transfusion in total knee and hip arthroplasty. J Orthop Surg Res. 2019;14:273.","journal-title":"J Orthop Surg Res"},{"key":"6857_CR3","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1186\/s13018-019-1296-5","volume":"14","author":"F Pennestr\u00ec","year":"2019","unstructured":"Pennestr\u00ec F, Maffulli N, Sirtori P, Perazzo P, Negrini F, Banfi G, Peretti GM. Blood management in fast-track orthopedic surgery: an evidence-based narrative review. J Orthop Surg Res. 2019;14:263.","journal-title":"J Orthop Surg Res"},{"key":"6857_CR4","doi-asserted-by":"publisher","first-page":"S63","DOI":"10.1016\/j.arth.2021.08.018","volume":"37","author":"DE DeMik","year":"2022","unstructured":"DeMik DE, Carender CN, Glass NA, Brown TS, Callaghan JJ, Bedard NA. Who is still receiving blood transfusions after primary and revision total joint arthroplasty? J Arthroplasty. 2022;37:S63-S9.e1.","journal-title":"J Arthroplasty."},{"key":"6857_CR5","doi-asserted-by":"publisher","first-page":"4386","DOI":"10.1038\/s41598-021-82779-z","volume":"11","author":"C Pempe","year":"2021","unstructured":"Pempe C, Werdehausen R, Pieroh P, Federbusch M, Petros S, Henschler R, Roth A, Pfrepper C. Predictors for blood loss and transfusion frequency to guide blood saving programs in primary knee- and hip-arthroplasty. Sci Rep. 2021;11:4386.","journal-title":"Sci Rep"},{"key":"6857_CR6","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.artd.2022.01.033","volume":"14","author":"DS Iacobelli","year":"2022","unstructured":"Iacobelli DS, Syku M, Abutalib Z, Berliner ZP, Joseph A, Cushner F, Boettner F, Rodriguez JA. Transfusion avoidance in severely anemic total hip and total knee arthroplasty patients: an analysis of risk. Arthroplast Today. 2022;14:128\u201332.","journal-title":"Arthroplast Today"},{"key":"6857_CR7","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1302\/2633-1462.57.BJO-2023-0157.R1","volume":"5","author":"N Mei\u00dfner","year":"2024","unstructured":"Mei\u00dfner N, Strahl A, Rolvien T, Halder AM, Schrednitzki D. Blood transfusion in elective total hip arthroplasty: can patient-specific parameters predict transfusion? Bone Jt Open. 2024;5:560\u20134.","journal-title":"Bone Jt Open"},{"key":"6857_CR8","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1097\/ALN.0b013e3181e08e97","volume":"113","author":"DR Spahn","year":"2010","unstructured":"Spahn DR. Anemia and patient blood management in hip and knee surgery: a systematic review of the literature. Anesthesiology. 2010;113:482\u201395.","journal-title":"Anesthesiology"},{"key":"6857_CR9","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1016\/j.arth.2021.01.018","volume":"36","author":"A Bailey","year":"2021","unstructured":"Bailey A, Eisen I, Palmer A, Beaul\u00e9 PE, Fergusson DA, Grammatopoulos G. Preoperative Anemia in Primary Arthroplasty Patients-Prevalence, Influence on Outcome, and the Effect of Treatment. J Arthroplasty. 2021;36:2281\u20139.","journal-title":"J Arthroplasty"},{"key":"6857_CR10","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1007\/s11999-014-3819-z","volume":"473","author":"H Bedair","year":"2015","unstructured":"Bedair H, Yang J, Dwyer MK, McCarthy JC. Preoperative erythropoietin alpha reduces postoperative transfusions in THA and TKA but may not be cost-effective. Clin Orthop Relat Res. 2015;473:590\u20136.","journal-title":"Clin Orthop Relat Res"},{"key":"6857_CR11","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.3389\/fphar.2020.01110","volume":"11","author":"XZ Guan","year":"2020","unstructured":"Guan XZ, Wang LL, Pan X, Liu L, Sun XL, Zhang XJ, Wang DQ, Yu Y. Clinical indications of recombinant human erythropoietin in a single center: a 10-year retrospective study. Front Pharmacol. 2020;11:1110.","journal-title":"Front Pharmacol"},{"key":"6857_CR12","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1097\/ALN.0000000000000134","volume":"120","author":"C Van So-Osman","year":"2014","unstructured":"So-Osman C, Nelissen RG, Koopman-van Gemert AW, Kluyver E, Poll RG, Onstenk R, Van Hilten JA, Jansen-Werkhoven TM, van den Hout WB, Brand R, Brand A. Patient blood management in elective total hip- and knee-replacement surgery (Part 1): a randomized controlled trial on erythropoietin and blood salvage as transfusion alternatives using a restrictive transfusion policy in erythropoietin-eligible patients. Anesthesiology. 2014;120:839\u201351.","journal-title":"Anesthesiology"},{"key":"6857_CR13","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3928\/01477447-20110427-11","volume":"34","author":"H Hourlier","year":"2011","unstructured":"Hourlier H, Fennema P. Chemoprophylaxis without intra-articular wound drainage can replace autotransfusion in primary TKA. Orthopedics. 2011;34:154.","journal-title":"Orthopedics"},{"key":"6857_CR14","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1186\/s13018-023-04404-1","volume":"18","author":"H Hourlier","year":"2023","unstructured":"Hourlier H, Fennema P. An observational study of an adjusted patient blood management protocol intended to lower rates of transfusion following total knee arthroplasty in patients with preoperative anemia. J Orthop Surg Res. 2023;18:918.","journal-title":"J Orthop Surg Res"},{"key":"6857_CR15","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1097\/00000542-194105000-00004","volume":"2","author":"M Saklad","year":"1941","unstructured":"Saklad M. Grading of patients for surgical procedures. Anesthesiol. 1941;2:281\u20134.","journal-title":"Anesthesiol"},{"key":"6857_CR16","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s00402-025-05764-5","volume":"145","author":"H Hourlier","year":"2025","unstructured":"Hourlier H, Fricault G, Fennema P. Blood management protocol for baseline anemic patients undergoing hip arthroplasty. Arch Orthop Trauma Surg. 2025;145:143.","journal-title":"Arch Orthop Trauma Surg"},{"key":"6857_CR17","first-page":"44","volume":"16","author":"H Hourlier","year":"2018","unstructured":"Hourlier H, Fennema P. Tranexamic acid use and risk of thrombosis in regular users of antithrombotics undergoing primary total knee arthroplasty: a prospective cohort study. Blood Transfus. 2018;16:44\u201352.","journal-title":"Blood Transfus"},{"key":"6857_CR18","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1016\/S0140-6736(02)08648-8","volume":"359","author":"AG Turpie","year":"2002","unstructured":"Turpie AG, Bauer KA, Eriksson BI, Lassen MR, Committee PSS. Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip-replacement surgery: a randomised double-blind trial. Lancet. 2002;359:1721\u20136.","journal-title":"Lancet"},{"key":"6857_CR19","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s00264-016-3170-y","volume":"41","author":"N Reina","year":"2017","unstructured":"Reina N, Fennema P, Hourlier H. The impact of mild peri-operative hypothermia on the effectiveness of tranexamic acid in total hip arthroplasty. Int Orthop. 2017;41:55\u201360.","journal-title":"Int Orthop"},{"key":"6857_CR20","first-page":"137","volume":"59","author":"F Canillas","year":"2015","unstructured":"Canillas F, G\u00f3mez-Ram\u00edrez S, Garc\u00eda-Erce JA, Pav\u00eda-Molina J, G\u00f3mez-Luque A, Mu\u00f1oz M. Patient blood management in orthopaedic surgery. Rev Esp Cir Ortop Traumatol. 2015;59:137\u201349.","journal-title":"Rev Esp Cir Ortop Traumatol"},{"key":"6857_CR21","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1007\/BF03027722","volume":"52","author":"N Rosencher","year":"2005","unstructured":"Rosencher N, Poisson D, Albi A, Aperce M, Barre J, Samama CM. Two injections of erythropoietin correct moderate anemia in most patients awaiting orthopedic surgery. Can J Anaesth. 2005;52:160\u20135.","journal-title":"Can J Anaesth"},{"key":"6857_CR22","doi-asserted-by":"publisher","first-page":"845","DOI":"10.7326\/0003-4819-133-11-200012050-00008","volume":"133","author":"BG Feagan","year":"2000","unstructured":"Feagan BG, Wong CJ, Kirkley A, Johnston DW, Smith FC, Whitsitt P, Wheeler SL, Lau CY. Erythropoietin with iron supplementation to prevent allogeneic blood transfusion in total hip joint arthroplasty. A randomized, controlled trial. Ann Intern Med. 2000;133:845\u201354.","journal-title":"Ann Intern Med"},{"key":"6857_CR23","first-page":"201","volume":"26","author":"PK Chan","year":"2020","unstructured":"Chan PK, Hwang YY, Cheung A, Yan CH, Fu H, Chan T, Fung WC, Cheung MH, Chan VWK, Chiu KY. Blood transfusions in total knee arthroplasty: a retrospective analysis of a multimodal patient blood management programme. Hong Kong Med J. 2020;26:201\u20137.","journal-title":"Hong Kong Med J"},{"key":"6857_CR24","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13018-015-0188-6","volume":"10","author":"MS Carling","year":"2015","unstructured":"Carling MS, Jeppsson A, Eriksson BI, Brisby H. Transfusions and blood loss in total hip and knee arthroplasty: a prospective observational study. J Orthop Surg Res. 2015;10:48.","journal-title":"J Orthop Surg Res"},{"issue":"24","key":"6857_CR25","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1001\/jama.2025.20841","volume":"334","author":"P Kougias","year":"2025","unstructured":"Kougias P, Sharath SE, Zhan M, Carson JL, Norman LE, Mi Z, Pal R, Dosluoglu H, Modrall JG, Sarosi GA Jr., et al. Liberal or restrictive postoperative transfusion in patients at high cardiac risk: the TOP randomized clinical trial. JAMA. 2025;334(24):2174.","journal-title":"JAMA"},{"issue":"Suppl 1","key":"6857_CR26","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/anae.14466","volume":"74","author":"KE Munting","year":"2019","unstructured":"Munting KE, Klein AA. Optimisation of pre-operative anaemia in patients before elective major surgery--why, who, when and how? Anaesthesia. 2019;74(Suppl 1):49\u201357.","journal-title":"Anaesthesia"},{"key":"6857_CR27","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1007\/BF03016277","volume":"52","author":"K Karkouti","year":"2005","unstructured":"Karkouti K, McCluskey SA, Evans L, Mahomed N, Ghannam M, Davey R. Erythropoietin is an effective clinical modality for reducing RBC transfusion in joint surgery. Can J Anaesth. 2005;52:362\u20138.","journal-title":"Can J Anaesth"},{"key":"6857_CR28","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1056\/NEJM199703273361307","volume":"336","author":"LT Goodnough","year":"1997","unstructured":"Goodnough LT, Monk TG, Andriole GL. Erythropoietin therapy. N Engl J Med. 1997;336:933\u20138.","journal-title":"N Engl J Med"}],"container-title":["Journal of Orthopaedic Surgery and Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13018-026-06857-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-026-06857-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-026-06857-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T01:31:01Z","timestamp":1781659861000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13018-026-06857-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,18]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6857"],"URL":"https:\/\/doi.org\/10.1186\/s13018-026-06857-6","relation":{},"ISSN":["1749-799X"],"issn-type":[{"value":"1749-799X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,18]]},"assertion":[{"value":"29 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study did not alter standard clinical practice and was conducted in accordance with French law. In accordance with French regulations governing retrospective analyses of anonymized routinely collected clinical data (Code de la sant\u00e9 publique), formal approval by an institutional review board or ethics committee was not required. The study was conducted in accordance with the Declaration of Helsinki. Written informed consent was obtained from all patients prior to surgery.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}],"article-number":"340"}}